Determine That an Abbreviated New Drug Application (ANDA) Oxycodone Hydrochloride Extended-Release Capsules may be Submitted and be Considered Bioequivalent to the Reference Listed Drug (RLD) Oxycontin® (Oxycodone Hydrochloride Controlled-Release) Tablets
🏛 Food and Drug Administration (FDA)FDA-2012-P-1180
Documents
0
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
No documents mirrored for this docket yet.